…
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Aveanna Healthcare Holdings provides in-home pediatric and adult nursing, therapy and personal-care services across the United States to Medicaid, Medicare and commercial payors. Long-term growth may be supported by aging demographics, policy shifts favoring home-based care and service/geographic expansion, and investors may find the company attractive for exposure to recurring payor-funded home health demand.
Key investment risks include reimbursement and regulatory changes, staffing shortages and wage pressure, heavy Medicaid exposure and execution risk from integrating acquisitions and scaling operations.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 106.95M | 5.07M | -139.00M | -663.81M | -113.58M |
| Net income | 225.03M | -10.93M | -134.52M | -662.03M | -117.04M |
| Selling general administrative | 526.74M | 470.47M | 464.74M | 483.95M | 427.77M |
| Selling and marketing expenses | - | 1.85M | 8.57M | - | - |
| Gross profit | 805.15M | 635.54M | 595.43M | 553.23M | 542.40M |
| Reconciled depreciation | 28.22M | 31.16M | 32.30M | 38.82M | 35.39M |
| Ebit | 250.80M | 156.21M | 9.07M | 26.30M | 95.97M |
| Ebitda | 274.56M | 187.38M | 39.17M | 65.12M | 131.36M |
| Depreciation and amortization | 23.77M | 31.16M | 30.10M | 38.82M | 35.39M |
| Non operating income net other | - | - | - | 86.18M | -8.54M |
| Operating income | 265.38M | 139.79M | 8.07M | 26.30M | 95.97M |
| Other operating expenses | 2167.82M | 1884.72M | 1887.14M | 1754.48M | 1584.19M |
| Interest expense | 140.09M | 156.60M | 153.25M | 99.94M | 68.93M |
| Tax provision | -118.09M | 16.00M | 0.02M | -1.78M | 3.47M |
| Interest income | 2.83M | 0.50M | 0.55M | 0.68M | 0.25M |
| Net interest income | -137.25M | -156.10M | -146.97M | -107.04M | -68.68M |
| Non recurring | - | - | - | 675.45M | 130.53M |
| Income tax expense | -118.09M | 16.00M | -4.47M | -1.78M | 3.47M |
| Total revenue | 2433.20M | 2024.51M | 1895.21M | 1787.64M | 1678.62M |
| Total operating expenses | 539.77M | 495.75M | 587.36M | 520.06M | 447.98M |
| Cost of revenue | 1628.05M | 1388.96M | 1299.78M | 1234.42M | 1136.21M |
| Total other income expense net | -158.43M | -134.72M | -147.07M | -690.12M | -209.54M |
| Net income from continuing ops | 225.03M | -10.93M | -346.57M | -662.03M | -117.04M |
| Net income applicable to common shares | - | - | - | -662.03M | -117.04M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2025.72M | 1663.39M | 1637.16M | 1711.76M | 2334.37M |
| Intangible assets | 92.56M | 89.57M | 94.01M | 95.86M | 102.85M |
| Other current assets | 50.86M | 30.72M | 25.14M | 9.81M | 9.20M |
| Total liab | 1830.53M | 1785.48M | 1764.60M | 1715.93M | 1696.42M |
| Total stockholder equity | 194.46M | -122.09M | -129.57M | -4.17M | 637.95M |
| Deferred long term liab | - | - | - | 3.84M | 3.05M |
| Other current liab | 363.23M | 167.13M | 141.59M | 249.58M | 129.00M |
| Common stock | 2.11M | 1.93M | 1.91M | 1.89M | 1.85M |
| Capital stock | 2.11M | 1.93M | 1.91M | 1.89M | 1.85M |
| Retained earnings | -1157.13M | -1382.16M | -1371.23M | -1236.71M | -574.68M |
| Other liab | - | - | - | 62.54M | 64.35M |
| Good will | 1121.04M | 1054.55M | 1054.55M | 1159.69M | 1835.58M |
| Other assets | - | - | - | 27.36M | 33.36M |
| Cash | 193.26M | 84.29M | 43.94M | 19.22M | 30.49M |
| Total current liabilities | 424.46M | 402.17M | 354.76M | 326.50M | 344.83M |
| Current deferred revenue | - | - | - | 3.84M | 135.96M |
| Net debt | 1150.07M | 1417.69M | 1455.25M | 1336.13M | 1267.95M |
| Short term debt | 29.26M | 198.60M | 183.04M | 28.45M | 27.25M |
| Short long term debt | 184.43M | 14.35M | 13.15M | 15.38M | 13.71M |
| Short long term debt total | 1343.33M | 1501.97M | 1499.19M | 1355.35M | 1298.44M |
| Other stockholder equity | 1349.48M | 1256.68M | 1237.62M | 1230.65M | 1210.78M |
| Property plant equipment | - | - | - | 22.75M | 31.37M |
| Total current assets | 560.23M | 392.67M | 314.89M | 269.75M | 279.21M |
| Net tangible assets | - | - | - | -1259.73M | -1300.48M |
| Net receivables | 313.36M | 277.66M | 245.81M | 225.63M | 225.29M |
| Long term debt | 1286.65M | 1271.66M | 1276.34M | 1281.08M | 1226.52M |
| Inventory | - | - | - | 15.09M | 14.23M |
| Accounts payable | 31.97M | 36.44M | 30.13M | 44.62M | 52.62M |
| Accumulated other comprehensive income | - | 1.46M | 2.13M | - | - |
| Common stock total equity | - | - | - | 1.89M | 1.85M |
| Retained earnings total equity | - | - | - | -1236.71M | -574.68M |
| Non currrent assets other | 8.21M | 7.33M | 4.67M | 105.26M | 33.36M |
| Non current assets total | 1465.48M | 1270.72M | 1322.28M | 1442.01M | 2055.16M |
| Capital lease obligations | 43.42M | 47.22M | 54.70M | 58.89M | 58.22M |
| Long term debt total | - | - | - | 1281.08M | 1226.52M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -6.32M | -10.43M | -11.72M | 1.03M |
| Change to liabilities | - | - | - | 3.50M | -23.61M |
| Total cashflows from investing activities | -22.30M | -6.32M | -8.79M | -25.29M | -681.83M |
| Net borrowings | -3.76M | -2.36M | -4.68M | 68.10M | 1416.85M |
| Total cash from financing activities | 9.03M | 14.03M | 10.85M | 62.42M | 586.33M |
| Change to operating activities | - | - | - | -35.07M | -50.82M |
| Net income | 225.03M | -10.93M | -134.52M | -662.03M | -117.04M |
| Change in cash | 108.97M | 40.35M | 24.73M | -11.27M | -106.86M |
| Begin period cash flow | 84.29M | 43.94M | 19.22M | 30.49M | 137.34M |
| End period cash flow | 193.26M | 84.29M | 43.94M | 19.22M | 30.49M |
| Total cash from operating activities | 122.24M | 32.64M | 22.67M | -48.40M | -11.35M |
| Issuance of capital stock | - | - | - | 0.00M | 477.69M |
| Depreciation | 28.22M | 31.16M | 30.10M | 38.82M | 35.39M |
| Other cashflows from investing activities | - | - | -2.68M | -13.57M | -681.83M |
| Change to inventory | - | - | - | - | -27.06M |
| Change to account receivables | -30.22M | -28.64M | -15.32M | -3.23M | -8.81M |
| Sale purchase of stock | - | - | - | 4.01M | 475.51M |
| Other cashflows from financing activities | 6.27M | 13.30M | 15.63M | 116.97M | 1421.58M |
| Change to netincome | - | - | - | 580.23M | 85.14M |
| Capital expenditures | 7.45M | 6.32M | 6.12M | 12.01M | 15.95M |
| Change receivables | - | - | - | -3.23M | -8.81M |
| Cash flows other operating | - | - | - | 4.03M | 1.81M |
| Cash and cash equivalents changes | - | - | - | -11.27M | -106.86M |
| Change in working capital | -52.66M | -29.97M | -23.40M | -42.22M | -71.33M |
| Stock based compensation | 25.06M | 17.46M | 13.16M | 15.89M | 14.43M |
| Other non cash items | 64.67M | 23.87M | 136.32M | 601.26M | 125.89M |
| Free cash flow | 114.79M | 26.32M | 16.56M | -60.41M | -27.30M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings Inc |
-0.27 2.44% |
10.58 | 11.45 | 14.99 | 1.20 | 10.91 | 1.75 | 14.98 |
| HCA HCA Healthcare, Inc. |
-10.87 2.28% |
465.48 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-7.50 2.76% |
263.84 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
-0.34 2.32% |
14.34 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
-1.31 23.52% |
4.26 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
400 Interstate North Parkway SE, Atlanta, GA, United States, 30339
770 441 1580
3500
| Name | Title | Year Born |
|---|---|---|
| Mr. Rodney D. Windley | Exec. Chairman | 1948 |
| Mr. Tony Strange | CEO & Director | 1963 |
| Mr. David Afshar CPA | Chief Financial Officer | 1972 |
| Mr. Jeffrey Shaner | Chief Operating Officer | 1973 |
| Mr. Shannon L. Drake | Gen. Counsel & Chief Legal Officer | 1976 |
| Mr. Ed Reisz | Chief Admin. Officer | 1959 |
| Mr. Patrick A. Cunningham | Chief Compliance Officer | 1956 |
| Ms. Beth Rubio | Chief Clinical Officer | 1957 |
| Ms. Korey Hinz | Pres of Medical Solutions | NA |
| Mr. Robert Radics | Pres of Home Health & Hospice | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.